» Articles » PMID: 23335049

Management of Distal Rectal Cancer: Results from a National Survey

Overview
Journal Updates Surg
Specialty General Surgery
Date 2013 Jan 22
PMID 23335049
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Owing to the complexity of distal rectal cancer its management requires a multidisciplinary approach. The diagnosis and the response after neoadjuvant chemoradiotherapy are not easy to assess and therefore the surgical approach is heterogeneous. The purpose of this survey is to evaluate the experiences of members of the Italian Society of Surgery in diagnosis and treatment strategies for rectal cancer and compare it with international practice. A questionnaire was devised comprising 18 questions with 11 sub-items making a total of 29 questions and submitted online to all the 2,500 members of the SIC starting from July 2010. The survey was completed in June 2011. The overall response rate was 17.8 % (444). The majority of the Italian surgeons' responses were in line with the international consensus reflecting the complex management of distal rectal cancer. Other opinions, especially those on staging, diverge from the common view of MRI being the gold standard in the assessment of loco-regional diffusion of the disease and on the superiority of FDG PET-CT versus CT for systemic staging. The timing for the re-staging and for surgery following neoadjuvant chemoradiotherapy does not reflect the international opinion. Italian surgeons are also exposed to the common difficulties encountered internationally in the management of distal rectal cancer. Probably, the implementation of an Italian rectal cancer registry and of many national and international multicentre studies may improve the management of rectal cancer in Italy.

Citing Articles

Consequences of defensive medicine, second victims, and clinical-judicial syndrome on surgeons' medical practice and on health service.

Pellino I, Pellino G Updates Surg. 2015; 67(4):331-7.

PMID: 26650202 DOI: 10.1007/s13304-015-0338-8.


Prophylactic negative pressure wound therapy in colorectal surgery. Effects on surgical site events: current status and call to action.

Pellino G, Sciaudone G, Selvaggi F, Canonico S Updates Surg. 2015; 67(3):235-45.

PMID: 25921360 DOI: 10.1007/s13304-015-0298-z.

References
1.
Kalady M, Campos-Lobato L, Stocchi L, Geisler D, Dietz D, Lavery I . Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009; 250(4):582-9. DOI: 10.1097/SLA.0b013e3181b91e63. View

2.
Gerard J, Rostom Y, Gal J, Benchimol D, Ortholan C, Aschele C . Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials. Crit Rev Oncol Hematol. 2011; 81(1):21-8. DOI: 10.1016/j.critrevonc.2011.02.001. View

3.
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

4.
Taylor F, Mangat N, Swift I, Brown G . Proforma-based reporting in rectal cancer. Cancer Imaging. 2010; 10 Spec no A:S142-50. PMC: 2967144. DOI: 10.1102/1470-7330.2010.9092. View

5.
Maas M, Nelemans P, Valentini V, Das P, Rodel C, Kuo L . Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010; 11(9):835-44. DOI: 10.1016/S1470-2045(10)70172-8. View